Auro Laboratories Limited disclosed the resignation of Mr. Kuntal Pancholi as Chief Financial Officer (CFO) of the company with immediate effect from the closure of business hours on May 28, 2026.
Consequently, Mr. Pancholi will cease to be a Key Managerial Personnel under the provisions of Section 203 and other applicable provisions of the Companies Act, 2013 effective May 28, 2026.
The company received confirmation from Mr. Pancholi that there are no other material reasons for his resignation beyond those mentioned in his resignation letter. The resignation was submitted due to personal reasons.
The disclosure was made under Regulation 30 of the SEBI (LODR) Regulations, 2015 read with SEBI Circular HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026. The required details are provided in Annexure A.
Annexure A Details
- Date of cessation: May 28, 2026
- Reason for change: As mentioned in the enclosed Resignation Letter
- Brief profile: Not applicable
- Disclosure of relationships between directors: Not applicable
- Regulation 30 disclosure: Resignation Letter is attached
Resignation Letter Contents
Mr. Kuntal Pancholi formally resigned from his position as Chief Financial Officer and Key Managerial Personnel due to personal reasons. He requested to be relieved from his responsibilities effective from the close of business hours of May 28, 2026. The letter expressed gratitude to the Board, leadership team, and colleagues, and wished the company continued success and sustained growth.